Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANISHA LAQUISE STEVENSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1649620261
CMS profile
4221806
Location
FLEMING ISLAND, FL

General Payments · PY2019–2024

$9,232.46

  • Reported across 560 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$684.37

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $684.37 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $301.76 14
Novo Nordisk AS $149.41 10
Boehringer Ingelheim Pharmaceuticals, Inc. $57.09 3
GlaxoSmithKline, LLC. $46.00 3
Acerta Pharma LLC $42.08 2
Phathom Pharmaceuticals, Inc. $20.89 1
Astellas Pharma US Inc $20.58 1
Lilly USA, LLC $19.36 1
PFIZER INC. $13.98 1
Amgen Inc. $13.22 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $34.12 2
PY2020 $1,280.84 69
PY2021 $2,980.37 204
PY2022 $2,550.42 154
PY2023 $1,702.34 94
PY2024 $684.37 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.69 01/25/2024 Food and Beverage Undisputed 01/23/2026 1106164041 CMS
ABBVIE INC. $23.86 02/01/2024 Food and Beverage Undisputed 01/23/2026 1106164043 CMS
ABBVIE INC. $24.93 02/19/2024 Food and Beverage Undisputed 01/23/2026 1106164045 CMS
ABBVIE INC. $11.61 03/05/2024 Food and Beverage Undisputed 01/23/2026 1106164047 CMS
ABBVIE INC. $15.63 03/14/2024 Food and Beverage Undisputed 01/23/2026 1106164049 CMS
ABBVIE INC. $28.01 03/21/2024 Food and Beverage Undisputed 01/23/2026 1106164051 CMS
ABBVIE INC. $4.79 04/09/2024 Food and Beverage Undisputed 01/23/2026 1106164053 CMS
ABBVIE INC. $27.85 04/25/2024 Food and Beverage Undisputed 01/23/2026 1106164055 CMS
ABBVIE INC. $32.68 06/10/2024 Food and Beverage Undisputed 01/23/2026 1106164057 CMS
ABBVIE INC. $25.64 07/08/2024 Food and Beverage Undisputed 01/23/2026 1106164059 CMS
ABBVIE INC. $13.70 08/14/2024 Food and Beverage Undisputed 01/23/2026 1106164061 CMS
ABBVIE INC. $9.46 09/19/2024 Food and Beverage Undisputed 01/23/2026 1106164063 CMS
ABBVIE INC. $28.01 11/26/2024 Food and Beverage Undisputed 01/23/2026 1106164065 CMS
ABBVIE INC. $22.90 12/06/2024 Food and Beverage Undisputed 01/23/2026 1106164067 CMS
Amgen Inc. $13.22 02/22/2024 Food and Beverage Undisputed 01/23/2026 1111716736 CMS
Astellas Pharma US Inc $20.58 11/26/2024 Food and Beverage Undisputed 01/23/2026 1139434052 CMS
AstraZeneca Pharmaceuticals LP $14.84 01/23/2024 Food and Beverage Undisputed 01/23/2026 1104319552 CMS
AstraZeneca Pharmaceuticals LP $27.24 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105568731 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.94 01/08/2024 Food and Beverage Undisputed 01/23/2026 1118095388 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.88 01/11/2024 Food and Beverage Undisputed 01/23/2026 1118095386 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.27 05/30/2024 Food and Beverage Undisputed 01/23/2026 1118095390 CMS
GlaxoSmithKline, LLC. $17.17 01/04/2024 Food and Beverage Undisputed 01/23/2026 1116569563 CMS
GlaxoSmithKline, LLC. $14.40 05/09/2024 Food and Beverage Undisputed 01/23/2026 1116722901 CMS
GlaxoSmithKline, LLC. $14.43 06/21/2024 Food and Beverage Undisputed 01/23/2026 1116606224 CMS
Lilly USA, LLC $19.36 09/23/2024 Food and Beverage Undisputed 01/23/2026 1136115758 CMS
Novo Nordisk Inc $6.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1096921832 CMS
Novo Nordisk Inc $15.62 03/04/2024 Food and Beverage Undisputed 01/23/2026 1097012192 CMS
Novo Nordisk Inc $7.21 04/17/2024 Food and Beverage Undisputed 01/23/2026 1097791829 CMS
Novo Nordisk Inc $16.79 05/07/2024 Food and Beverage Undisputed 01/23/2026 1097820885 CMS
Novo Nordisk Inc $17.75 06/18/2024 Food and Beverage Undisputed 01/23/2026 1096594930 CMS
Novo Nordisk Inc $23.08 08/22/2024 Food and Beverage Undisputed 01/23/2026 1096625334 CMS
Novo Nordisk Inc $20.47 09/17/2024 Food and Beverage Undisputed 01/23/2026 1097438926 CMS
Novo Nordisk Inc $15.83 09/24/2024 Food and Beverage Undisputed 01/23/2026 1096656087 CMS
Novo Nordisk Inc $12.53 10/31/2024 Food and Beverage Undisputed 01/23/2026 1096589630 CMS
Novo Nordisk Inc $14.00 11/19/2024 Food and Beverage Undisputed 01/23/2026 1096981329 CMS
PFIZER INC. $13.98 02/27/2024 Food and Beverage Undisputed 01/23/2026 1131165914 CMS
Phathom Pharmaceuticals, Inc. $20.89 11/14/2024 Food and Beverage Undisputed 01/23/2026 1151130044 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.